Skip to main content

Mª Teresa Gené Juyent

Institutions of which they are part

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Mª Teresa Gené Juyent

Institutions of which they are part

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Related news

The annual event offered a space for dialogue between the scientific community and society on how to address the future of ageing through research and innovation.

Docetaxel, carried by Soluplus, proved to be the most effective and least toxic combination to cross the blood-brain barrier and attack the tumour directly.

Based on the study led by VHIR, a clinical trial has been approved for patients with locally advanced pancreatic cancer.

Related professionals

Ernesto Trallero Araguas

Ernesto Trallero Araguas

Main researcher
Rheumatology
Read more
Claire Diot

Claire Diot

Administration and Management
Childhood Cancer and Blood Disorders
Read more
Carlos Nos  Llopis

Carlos Nos Llopis

Research technician
Clinical Neuroimmunology
Read more
Mercedes López González

Mercedes López González

Main researcher
Kidney Physiopathology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.